Expert Review of Anticancer Therapy

Title Publication Date Language Citations
Mathematical modeling of cancer progression and response to chemotherapy2006/10/01English78
Temozolomide: a novel oral alkylating agent2001/06/01English77
Triple-negative breast cancer: promising prognostic biomarkers currently in development2021/02/01English77
Molecular markers for bladder cancer: the road to a multimarker approach2007/12/01English75
Diarrhea associated with afatinib: an oral ErbB family blocker2013/06/01English75
Desmoid tumors: need for an individualized approach2009/04/01English74
Targeted therapy for non-small-cell lung cancer: past, present and future2013/06/01English73
Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer2009/10/01English73
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies2007/02/01English72
Review of image-guided radiation therapy2007/01/01English71
Urachal carcinoma: surgical and chemotherapeutic options2006/12/01English71
Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial2009/10/01English71
Managing side effects in adjuvant endocrine therapy for breast cancer2018/09/21English71
Satraplatin: an orally available platinum analog for the treatment of cancer2006/07/01English71
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer2015/12/10English70
Impact and treatment of cancer during pregnancy2004/10/01English70
New TNM classification for non-small-cell lung cancer2009/04/01English70
Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies2008/04/01English70
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy2007/07/01English70
Factors increasing local recurrence in breast-conserving surgery2005/08/01English70
Oral contraceptives and risk of ovarian and breast cancers inBRCAmutation carriers: a meta-analysis2011/08/01English70
First-line treatment of advanced ovarian cancer: current research and perspectives2010/01/01English70
Potential of CXCR4 antagonists for the treatment of metastatic lung cancer2011/04/01English69
Reactive oxygen species: an Achilles’ heel of melanoma?2008/11/01English69
Future applications of FGF/FGFR inhibitors in cancer2018/07/02English69
Pemetrexed (Alimta®): a novel multitargeted antifolate agent2003/04/01English68
Management Strategies for Recurrent Endometrial Cancer2018/07/04English67
Sorafenib: key lessons from over 10 years of experience2018/12/21English67
Regulation of androgen receptor signaling in prostate cancer2005/01/01English67
Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer2006/06/01English67